CLS Holdings USA (CLS Holdings USA) Risk Assessment

View and export this data going back to 2014. Start your Free Trial

What is CLS Holdings USA Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of CLS Holdings USA is: No Data: Cannot be evaluated.

Competitive Comparison of CLS Holdings USA's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CLS Holdings USA's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Risk Assessment distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Risk Assessment falls into.

CLS Holdings USA (OTCPK:CLSH) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

CLS Holdings USA Risk Assessment Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

CLS Holdings USA (CLS Holdings USA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (OTCPK:CLSH) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

CLSH:Canada

Address

1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102

Website

https://www.clsholdingsinc.com

CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.

Executives

Ross Silver	director	516 SW 13TH STREET, SUITE 201, BEND OR 97702
Andrew Glashow	director	1C BOWENS LANDING, NEWPORT RI 02840
Tribeca Investment Partners Pty Ltd	10 percent owner	LEVEL 23, 1 O'CONNELL STREET, SYDNEY C3 2000
David Zelinger	director	C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Charlene Soco	officer: Executive VP of Finance	C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Chetan Gulati	10 percent owner	28 REICHERT CIRCLE, WESTPORT CT 06880
Todd V Swanson	10 percent owner	10120 W. FLAMINGO ROAD, #4333, LAS VEGAS NV 89147
Gregg E. Carlson	officer: Chief Financial Officer	2342 MALAGA PEAK STREET, LAS VEGAS NV 89135
Navy Capital Green Management Llc	10 percent owner, other: See Remark(1)	482 BAYBERRY LANE, MOUNTAINSIDE NJ 07092
Navy Capital Green Co-invest Partners Llc	10 percent owner, other: See Remark(1)	28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Co-invest Fund, Llc	10 percent owner	28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Management Partners Llc	10 percent owner	28 REICHERT CIRCLE, WESTPORT CT 06880
John Kaden	10 percent owner	28 REICHERT CIRCLE, WESTPORT CT 06880
Sean Stiefel	10 percent owner	28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Fund, Lp	10 percent owner, other: See Remark(2)	NAVY CAPITAL GREEN MANAGEMENT, LLC, 28 REICHERT CIRCLE, WESTPORT CT 06880